Intraoperative ultrasound-based planning can effectively replace postoperative CT-based planning for high-dose-rate brachytherapy for prostate cancer.

PURPOSE: Ultrasound (US)-based planning for high-dose-rate brachytherapy allows prostate patients to be implanted, imaged, planned, and treated without changing position. This is advantageous with respect to accuracy and efficiency of treatment but is only valuable if plan quality relative to CT is maintained. This study evaluates any dosimetric impact of changing from CT- to US-based planning. METHODS AND MATERIALS: Thirty patients each were randomly selected from CT-planned and US-planned cohorts. All received single fraction high-dose-rate brachytherapy (15 Gy) followed by 37.5 Gy in 15 fractions external beam radiation therapy. Prostate V90, V100, V150, V200, D90, and the dose homogeneity index were compared. For the rectum, Dmax, D0.5cc, D1cc, V10, V50, and V80 were examined. For the urethra, only Dmax and D10 were considered. RESULTS: US plans had smaller 200% hot spots, although the dose homogeneity index for both was 0.7 ± 0.1. On average, plans using either modality satisfied planning goals. Although several parameters were significantly different between the two modalities (p < 0.05), the absolute differences were small. Of greatest, clinical relevance was the difference in frequency with which upper dose goals were exceeded. The prostate V200 goal was exceeded in 53% of CT-planned cases, but only 20% of those planned with US. The urethral D10 goal was never exceeded using US but was exceeded in 13% of CT cases. CONCLUSIONS: US planning results in plans that, clinically, are dosimetrically equivalent to CT-based planning. Upper dosimetric goals are, however, exceeded less often with US than with CT.

Assessing the role of volumetric modulated arc therapy (VMAT) relative to IMRT and helical tomotherapy in the management of localized, locally advanced, and post-operative prostate cancer.

PURPOSE: To quantify differences in treatment delivery efficiency and dosimetry between step-and-shoot intensity-modulated radiotherapy (IMRT), volumetric modulated arc therapy (VMAT), and helical tomotherapy (HT) for prostate treatment. METHODS AND MATERIALS: Twenty-five prostate cancer patients were selected retrospectively for this planning study. Treatment plans were generated for: prostate alone (n = 5), prostate + seminal vesicles (n = 5), prostate + seminal vesicles + pelvic lymph nodes (n = 5), prostate bed (n = 5), and prostate bed + pelvic lymph nodes (n = 5). Target coverage, dose homogeneity, integral dose, monitor units (MU), and sparing of organs at risk (OAR) were compared across techniques. Time required to deliver each plan was measured. RESULTS: The dosimetric quality of IMRT, VMAT, and HT plans were comparable for target coverage (planning target volume V95%, clinical target volume V100% all >98.7%) and sparing of organs at risk (OAR) for all treatment groups. Although HT resulted in a slightly higher integral dose and mean doses to the OAR, it yielded a lower maximum dose to all OAR examined. VMAT resulted in reductions in treatment times over IMRT (mean = 75%) and HT (mean = 70%). VMAT required 15-38% fewer monitor units than IMRT over all treatment volumes, with the reduction per fraction ranging from 100-423 MU from the smallest to largest volumes. CONCLUSIONS: VMAT improves efficiency of delivery for equivalent dosimetric quality as IMRT and HT across various prostate cancer treatment volumes in the intact and postoperative settings.

Optimization of high-dose-rate cervix brachytherapy applicator placement: the benefits of intraoperative ultrasound guidance.

PURPOSE: To promote efficient workflow for image-guided high-dose-rate (HDR) brachytherapy (BT) for cervix cancer by implementing intraoperative ultrasound (US) guidance for placement and optimization of intrauterine applicators. We sought to establish this as part of routine radiation oncology practice without radiology consultation. METHODS AND MATERIALS: Thirty-five consecutive insertions were performed in 21 women between July 2006 and March 2007. Cervical dilation, tandem selection and insertion were guided by transabdominal US. Final tandem position following vaginal applicator insertion was also confirmed by US. Computed tomography (CT) imaging was used for treatment planning and to assess perforation and applicator suitability for each patient anatomy. RESULTS: Intrauterine tandem insertion was successfully guided by US in the majority of procedures (34/35). CT imaging confirmed accurate placement within the uterine canal in each case, compared with a historic institutional perforation rate of 10%. Visualizing patient anatomy during insertion altered the selection of tandem length and angle in 49% of cases, resulting in improved applicator matching to anatomy. Average insertion time significantly decreased from 34 to 26 minutes (p=0.01). Requests for assistance from gynecologic surgical oncology declined from 38% to 5.7% of procedures. CONCLUSIONS: Intraoperative US guidance for cervix BT has been successfully implemented with staff and equipment from radiation oncology. Using US during every insertion has led to improved applicator selection and placement while decreasing procedure time and reducing out of department consultations. These changes have eliminated repeat insertions due to unfavorable applicator placement (as revealed on postoperative CT), thus improving department efficiency and quality of patient care.

Image-guided cervix high-dose-rate brachytherapy treatment planning: does custom computed tomography planning for each insertion provide better conformal avoidance of organs at risk?

PURPOSE: Intracavitary high-dose-rate (HDR) brachytherapy (BT) for cervical cancer involves multiple applicator insertions. Our study addresses whether customized three-dimensional plans generated for the first insertion (using computed tomography [CT] planning) can be applied to subsequent insertions without significant changes in dose distributions if identical applicators are used. METHODS AND MATERIALS: Twenty-seven patients were treated with external-beam radiotherapy, platinum-based chemotherapy, and HDR BT. Either tandem and ovoids (TO, n=12) or tandem and ring (TR, n=15) applicators were used, based on clinical indications. Postimplant CT scans were acquired and custom plans generated for each insertion. Dose parameters for organs at risk (OARs) from the second insertion were retrospectively compared to those that would have been delivered using the initial plan. RESULTS: Overall, we observed a significant increase (p<0.038) in dose to International Commission on Radiation Units and Measurement points and 2cm(3) volumes of bladder and rectum when a single plan was used. The sigmoid and small bowel exhibited a more variable increase in dose. Applicator-specific results revealed a significant increase (p<0.030) to dose points and volumes for the rectum and bladder for TR applicators. Conversely, dose values from the more flexible TO did not show any significant trend, exhibiting large interpatient variations. CONCLUSIONS: A duplication of planned dwell times and positions from one insertion to the next does not duplicate dose distributions in HDR cervix applications. A single plan used for an entire course of BT can result in significant increases to OAR doses for TR and unpredictable OAR doses for TO applicators. Treatment plans should be tailored for each insertion to reflect current applicator and anatomical geometry.

Bone-composition imaging using coherent-scatter computed tomography: assessing bone health beyond bone mineral density.

Quantitative analysis of bone composition is necessary for the accurate diagnosis and monitoring of metabolic bone diseases. Accurate assessment of the bone mineralization state is the first requirement for a comprehensive analysis. In diagnostic imaging, x-ray coherent scatter depends upon the molecular structure of tissues. Coherent-scatter computed tomography (CSCT) exploits this feature to identify tissue types in composite biological specimens. We have used CSCT to map the distributions of tissues relevant to bone disease (fat, soft tissue, collagen, and mineral) within bone-tissue phantoms and an excised cadaveric bone sample. Using a purpose-built scanner, we have measured hydroxyapatite (bone mineral) concentrations based on coherent-scatter patterns from a series of samples with varying hydroxyapatite content. The measured scatter intensity is proportional to mineral density in true g/cm3. Repeated measurements of the hydroxyapatite concentration in each sample were within, at most, 2% of each other, revealing an excellent precision in determining hydroxyapatite concentration. All measurements were also found to be accurate to within 3% of the known values. Phantoms simulating normal, over-, and under-mineralized bone were created by mixing known masses of pure collagen and hydroxyapatite. An analysis of the composite scatter patterns gave the density of each material. For each composite, the densities were within 2% of the known values. Collagen and hydroxyapatite concentrations were also examined in a bone-mimicking phantom, incorporating other bone constituents (fat, soft tissue). Tomographic maps of the coherent-scatter properties of each specimen were reconstructed, from which material-specific images were generated. Each tissue was clearly distinguished and the collagen-mineral ratio determined from this phantom was also within 2% of the known value. Existing bone analysis techniques cannot determine the collagen-mineral ratio in intact specimens. Finally, to demonstrate the in situ potential of this technique, the mineralization state of an excised normal cadaveric radius was examined. The average collagen-mineral ratio of the cortical bone derived from material-specific images of the radius was 0.53+/-0.04, which is in agreement with the expected value of 0.55 for healthy bones.

Establishing composition and structure of intact urinary calculi by x-ray coherent scatter for clinical laboratory investigations.

PURPOSE: Current urinary stone analysis techniques are limited in their abilities to simultaneously characterize composition and structure. Laboratory techniques such as IRS and x-ray diffractometry require small powdered samples for analysis, rendering composition results dependent on the choice of sample and its preparation. We investigated the application of x-ray CS analysis to identify topographic urinary stone composition ex vivo. CS is essentially a transmission based x-ray diffractometry method that depends on molecular structure and, therefore, can distinguish different compounds. Diagnostic x-ray equipment facilitates the examination of structural arrangements of minerals in intact calculi. MATERIALS AND METHODS: Tomographic images of intact calculi CS properties were acquired with a purposely built scanner. Composition is extracted from CS by fitting a library of common pure stone component CS signatures to those of the unknown sample in each image pixel. Two zones per stone were isolated (powdered) for IRS composition analysis for comparison with CS maps at these locations. Each stone was also independently analyzed for bulk composition by IRS analysis. RESULTS: CS composition maps revealed the spatial arrangement of minerals in intact calculi. IRS results showed good agreement with CS in the selected regions of interest. Bulk composition by IRS was noted to miss some important stone components, indicating that the choice of sample may skew composition results. CONCLUSIONS: CS from diagnostic x-rays can be used to identify structure and composition in mixed urinary calculi nondestructively. The tissue specific CS images presented support the development of CS analysis as a means of identifying stone composition characteristics in the laboratory.

Analysis of urinary stone components by x-ray coherent scatter: characterizing composition beyond laboratory x-ray diffractometry.

Monoenergetic x-ray diffraction (XRD) analysis is an established standard for the assessment of urinary stone composition. The inherent low energy of x-rays used (8 keV), however, restricts penetration depth and imposes a requirement for small powdered samples. A technique capable of producing detailed information regarding component structural arrangements in calculi non-destructively would provide clearer insights into causes of formation and subsequent growth and allow the selection of more appropriate courses of therapy. We describe a new method based on the detection of coherent scatter (CS) in stone components using polyenergetic x-rays (70 kVp) from diagnostic equipment. While the higher energy allows the analysis of intact calculi, the polyenergetic source causes an angular broadening of measured CS patterns. We show that it is possible to relate the polyenergetic (CS) and monoenergetic (XRD) measurements through a superposition integral of the monoenergetic XRD cross-section with a function representative of the polyenergetic spectrum used in CS. Experimentally acquired diffractometry cross-sections of the seven major urinary stone components were subjected to this operation, revealing good agreement of diffraction features with CS. Therefore, our CS analysis is sensitive to stone component structure, similar to conventional XRD analysis. This indicates that CS analysis can be used as a basis to classify urinary calculi by composition. The potential of identifying stone components non-destructively was demonstrated from a tomographic CS analysis of a stone-mimicking phantom. Tomographic composition maps were generated from CS patterns, showing the structural arrangement of multiple stone components within the phantom. CS analysis has the ability to detect components in the presence of many others. The ability to perform CS measurements in intact calculi would allow for the identification of stone structures critical to patient metaprophylaxis.

Laboratory coherent-scatter analysis of intact urinary stones with crystalline composition: a tomographic approach.

Knowledge of urinary stone composition and structure provides important insights in guiding treatment and preventing recurrence. No current method can successfully provide information relating structure and composition of intact stones. We are developing a tomographic technique that uses measures of coherently scattered diagnostic x-rays to yield stone composition. Coherent-scatter (CS) properties depend on molecular structure and are, therefore, sensitive to material composition. Powdered, amorphous or polycrystalline materials with no significant orientation produce circularly symmetric CS patterns. However, in materials with preferred crystallite orientation, like urinary stones, bright spots in CS patterns are observed. This compromises a composition analysis based on comparing CS measurements from calculi to a library of CS signatures from powdered chemicals. We show that a computed tomographic reconstruction of CS measurements using filtered backprojection (CSCT) effectively eliminates bright spots and yields CS patterns equivalent to powdered materials. This allows for direct comparison with a powdered chemical reference library to establish composition. Validation is achieved through a tomographic CS analysis of an aluminium (Al) rod phantom. Much like calculi, CS patterns from a solid polycrystalline Al rod exhibit diffraction spots, absent in the ring-like Al powder CS pattern. We show that the reconstructed Al CS cross-section is equivalent to its powdered counterpart and results in clearly defined composition images. The potential of CSCT to identify stone composition is demonstrated through images of intact stones deemed chemically pure by infrared spectroscopy. Computed tomographic reconstruction of CS signals allowed the generation of composition maps, showing the distribution of stone components. These images provide strong evidence that current laboratory techniques risk missing critical stone components due to inadequate sampling. This is of particular importance since follow-up treatments are based on these composition analyses. CS analysis can distinguish common stone components and can provide topographic composition maps of intact stones. Such details offer invaluable clinical information regarding stone formation, treatment and follow-up, and thus support the development of CS analysis as a laboratory stone analysis technique.

Material-specific analysis using coherent-scatter imaging.

Coherent-scatter computed tomography (CSCT) is a novel imaging method we are developing to produce cross-sectional images based on the low-angle (<10 degrees) scatter properties of tissue. At diagnostic energies, this scatter is primarily coherent with properties dependent upon the molecular structure of the scatterer. This facilitates the production of material-specific maps of each component in a conglomerate. Our particular goal is to obtain quantitative maps of bone-mineral content. A diagnostic x-ray source and image intensifier are used to acquire scatter patterns under first-generation CT geometry. An accurate measurement of the scatter patterns is necessary to correctly identify and quantify tissue composition. This requires corrections for exposure fluctuations, temporal lag in the intensifier, and self-attenuation within the specimen. The effect of lag is corrected using an approximate convolution method. Self-attenuation causes a cupping artifact in the CSCT images and is corrected using measurements of the transmitted primary beam. An accurate correction is required for reliable density measurements from material-specific images. The correction is shown to introduce negligible noise to the images and a theoretical expression for CSCT image SNR is confirmed by experiment. With these corrections, the scatter intensity is proportional to the number of scattering centers interrogated and quantitative measurements of each material (in g/cm3) are obtained. Results are demonstrated using both a series of poly(methyl methacrylate) (PMMA) sheets of increasing thickness (2-12 mm) and a series of 5 acrylic rods containing varying amounts of hydroxyapatite (0-0.400 g/cm3), simulating the physiological range of bone-mineral density (BMD) found in trabecular bone. The excellent agreement between known and measured BMD demonstrates the viability of CSCT as a tool for densitometry.

Predicting urinary stone composition using X-ray coherent scatter: a novel technique with potential clinical applications.

PURPOSE: Coherent scatter properties depend on the molecular structure of the scattering medium and measured scatter patterns are often characteristic of a chemical species. We explored the usefulness of coherent scatter analysis as a basis for identifying urinary calculus composition. MATERIALS AND METHODS: A laboratory system for collecting coherent scatter signals from biological specimens was developed. This technique uses a diagnostic x-ray tube and image intensifier, and measures coherent scatter from intact renal stones. The coherent scatter signatures of 6 common stone components (calcium oxalate monohydrate, calcium phosphate, calcium phosphate dihydrate, cystine, magnesium ammonium phosphate and uric acid) were acquired from pure chemical samples and stones identified by infrared spectroscopy as having a uniform composition. In addition, a sample of calculus identified as containing only calcium oxalate dihydrate was examined. The same fragmented stone samples analyzed by infrared spectroscopy were scanned using coherent scatter. RESULTS: In each case the scatter patterns from powdered chemicals and fragmented stones showed circular symmetry and consisted of a series of broad rings of various intensities. Each pure chemical sample produced a distinct coherent scatter pattern. The signatures of the stone specimens closely agreed with those of the chemical samples. CONCLUSIONS: These initial results indicate that coherent scatter analysis using diagnostic x-rays has potential as a tool for urinary calculous composition identification. Further developments in this technique may have the potential for determining the composition of a calculus in vivo before therapy, thus, aiding in therapy planning.